Oligodendroglioma epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
(Undo revision 1176249 by Sujit Routray (talk))
Line 8: Line 8:
==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Prevalence===
===Prevalence===
*Oligoastrocytoma is the third most common [[glioma]].<ref name=epidemiology1>Epidemiology of oligoastrocytoma. Dr Bruno Di Muzio and Dr Frank Gaillard et al. http://radiopaedia.org/articles/oligoastrocytoma</ref>
*Oligodendroglioma, although rare, is the third most common [[glioma]].<ref name=epidemiology>Epidemiology of oligodendroglioma. Dr Henry Knipe and Dr. Frank Gaillard et al. http://radiopaedia.org/articles/oligodendroglioma</ref>
*Oligodendroglioma accounts for 2%–5% of [[brain tumor|primary brain tumors]] and 5%–18% of all [[glioma|glial neoplasms]].
*Oligodendroglioma accounts for 2%–5% of [[brain tumor|primary brain tumors]] and 5%–18% of all [[glioma|glial neoplasms]].



Revision as of 20:36, 16 October 2015

Oligodendroglioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Oligodendroglioma from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Staging

History & Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Oligodendroglioma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Oligodendroglioma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Oligodendroglioma epidemiology and demographics

CDC on Oligodendroglioma epidemiology and demographics

Oligodendroglioma epidemiology and demographics in the news

Blogs on Oligodendroglioma epidemiology and demographics

Directions to Hospitals Treating Oligodendroglioma

Risk calculators and risk factors for Oligodendroglioma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Oligodendroglioma, although rare, is the third most common glioma.[1] The incidence of oligodendroglioma and anaplastic oligodendroglioma is estimated to be 0.32 and 0.17 cases per 100,000 individuals in the United States, respectively.[2] Oligodendroglioma is a disease that tends to affect the middle-aged adult population.[1] Oligodendroglioma most commonly occurs in the 4th and 5th decade of life. Males are more commonly affected with oligodendroglioma than females. The male to female ratio is approximately 2 to 1.[3] Oligodendroglioma usually affects individuals of the Caucasian race. African American, Latin American, and Asian individuals are less likely to develop oligodendroglioma.[4]

Epidemiology and Demographics

Prevalence

Incidence

  • The incidence of oligodendroglioma and anaplastic oligodendroglioma is estimated to be 0.32 and 0.17 cases per 100,000 individuals in the United States, respectively.[2]

Age

  • Oligodendroglioma is a disease that tends to affect the middle-aged adult population.[1]
  • Oligodendroglioma most commonly occurs in the 4th and 5th decade of life.
  • The median age at diagnosis is 47 years.[5]

Gender

  • Males are more commonly affected with oligodendroglioma than females. The male to female ratio is approximately 2 to 1.[3]

Race

  • Oligodendroglioma usually affects individuals of the Caucasian race. African American, Latin American, and Asian individuals are less likely to develop oligodendroglioma.[4]

References

  1. 1.0 1.1 1.2 1.3 Epidemiology of oligodendroglioma. Dr Henry Knipe and Dr. Frank Gaillard et al. http://radiopaedia.org/articles/oligodendroglioma
  2. 2.0 2.1 McCarthy BJ, Rankin KM, Aldape K, Bondy ML, Brännström T, Broholm H; et al. (2011). "Risk factors for oligodendroglial tumors: a pooled international study". Neuro Oncol. 13 (2): 242–50. doi:10.1093/neuonc/noq173. PMC 3064625. PMID 21149253.
  3. 3.0 3.1 Simonetti G, Gaviani P, Botturi A, Innocenti A, Lamperti E, Silvani A (2015). "Clinical management of grade III oligodendroglioma". Cancer Manag Res. 7: 213–23. doi:10.2147/CMAR.S56975. PMC 4524382. PMID 26251628.
  4. 4.0 4.1 Patterns by Gender for Selected Histologies CBTRUS Statistical Report: NPCR and SEER Data from 2004-2006. CBTRUS.org 2015. http://www.cbtrus.org/2010-NPCR-SEER/CBTRUS-WEBREPORT-Final-3-2-10.pdf
  5. Mørk SJ, Lindegaard KF, Halvorsen TB, Lehmann EH, Solgaard T, Hatlevoll R; et al. (1985). "Oligodendroglioma: incidence and biological behavior in a defined population". J Neurosurg. 63 (6): 881–9. doi:10.3171/jns.1985.63.6.0881. PMID 4056902.


Template:WikiDoc Sources